Pluri

Get ready for the Miss Universe competition!👑✨We’re proud to join MissUniverse Skincare in unveiling its new partnership with Cellav by Pluri, bringing cell-based skincare innovation to the global stage. 🌍#MissUniverse #RegenerativeBeauty @YakyYanay

Pluri Chairman Alejandro Weinstein speaks about Pluri’s cell-based technology and its large-scale potential. msn.com/en-us/technolo… #CellBased #CultivatedMeat #Biotech

Pluri is evolving into a commercially driven biotech, unlocking the value of its patented 3D cell-expansion platform across health and sustainable food. citybiz.co/article/799013… #Biotech #AgTech #FoodTech #Longevity #CellBased #Sustainability #ClimateResilience #FutureOfFood

youtu.be/2RK8OLxucWI How can biotechnology help solve some of the world’s biggest health and food challenges? I recently sat down with Yaky Yanay, CEO and President of @Pluribiotech (NASDAQCM, TASE: PLUR), to discuss how the company is scaling cell production in ways that could transform medicine, agriculture, and food systems. Pluri has developed a patented 3D cell expansion platform that enables large scale, cost efficient manufacturing of human, animal, and plant cells. Yanay describes it as a unified biotech platform with applications ranging from regenerative medicine and wound healing to cultivated coffee, cocoa, meat, and seafood. As global healthcare needs and food supply pressures grow, Pluri is focused on delivering science backed solutions using one powerful cell production system. #Biotechnology

Pluri Successfully Completes First Phase of Resbiomed Program for Placenta-Derived Collagen-Rich Biomaterials #PluriInc #Pluri #Biotech #Biotechnology #PluriCDMO #CDMO #RegenerativeMedicine #Biomaterials #Collagen#PlacentaDerived #CollagenRich #Bioprocessing #TissueEngineering

Pluri CEO Yaky Yanay speaks with Jane King about how a cell-based platform built over two decades is now enabling products across pharma, food, agriculture, and aesthetics. youtube.com/watch?v=2RK8OL… #Pluri #Biotech #CellBased #Innovation #Pharma #FoodTech #AgTech #Leadership

גאים לשתף כתבה ב־וואלה כסף על Pluri והקשר בין שוויון הזדמנויות לחדשנות. טכנולוגיה לגידול תאים בקנה מידה תעשייתי – מן החי ומן הצומח – עם יישומים ברפואה, פודטק ואגרוטק. שוויון והעסקה הוגנת הם מנוע לצמיחה 🔗 finance.walla.co.il/item/3809806 #Pluri #CellTechnology #Biotech #AgriTech #FoodTech

🚀 Pluri appoints Alejandro Weinstein as Chairman. His increased investment lifts his ownership to ~30%, underscoring strong confidence in Pluri’s platform and commercial roadmap. 🚀 #biotech #Pluri #Pluri #Biotech #Leadership #CellTech #Innovation #Healthcare #FoodTech #AgTech

Science meets beauty. ✨Meet Cellav Health and Aesthetics Ltd., powered by Pluri’s cell-based innovation to bring regenerative science to skincare. 💫Learn more: https ://pluri-biotech.com/revolutionizing-the-beauty-industry/ #BiotechBeauty #Innovation

Honored to be named Overall BioAgriculture Company of the Year by the Biotech Breakthrough Awards! 🌱🏆 Our ventures are also driving impact — from cell-based coffee (Coffeesai) and cacao (Kokomodo) to regenerative biotech 🔗 pluri-biotech.com/releases/pluri… #CellTherapy #Sustainability

Big news! 🌟 Pluri launches Cellav, our new health & aesthetics subsidiary and we’re partnering with Miss Universe Skincare to co-develop a revolutionary exosome-enhanced, cell-based skincare line launching in 2026: pluri-biotech.com/releases/pluri… #MissUniverseSkincare #Exosomes

🌍 Leading global players join forces with Pluri’s subsidiaries to transform food & agriculture. Each collaboration is funded by global partners to co-develop MVPs for a sustainable, cell-based future. 🌱 Read more: pluri-biotech.com/releases/leadi… #FoodTech #AgTech

Is biotech’s biggest challenge political? In @pharmaphorum Ep. 215, James Roosevelt Jr., healthcare leader & Pluri advisory board member, discusses FDA reform, access to cell therapies, and Pluri’s placenta-based innovation. 🎧 Listen: pharmaphorum.com/podcasts #HealthcarePolicy

🚀 Pluri CTO @LiorRaviv503 joins Teach Me in 10: Accelerating Cell & Gene Therapy 2025 by @Tech_Networks! He’ll spotlight scalable allogeneic cell therapy production — driving the future of accessible advanced therapies💡technologynetworks.com/tn/online-even… #CellTherapy #Biotech

Our Chief Scientific Officer Dr. Arthur Machlenkin co-authored a new publication in Drug Discovery Today: “Development of PLX-R18, a Promising and Novel Countermeasure for Radiation-Associated Injuries.” doi.org/10.1016/j.drud… #biotechnology #celltherapy #radiation

#BreastCancerAwarenessMonth At Pluri, we harness the power of cells — in health, agtech & foodtech — to create a healthier, more sustainable world. Health starts with awareness. Early detection saves lives. Schedule your screening or remind someone you love #EarlyDetection

☕ Brewing the Future of Coffee — in Mexico! Pluri’s subsidiary Coffeesai has joined forces with @INCAFECH01 to pioneer cell-based coffee manufacturing in Chiapas, Mexico’s leading coffee region. 🌱 Read more: pluri-biotech.com/releases/pluri… #Biotech #Agtech #Coffee #Innovation

As the Jewish new year dawns, we at Pluri renew our commitment to innovation — and to a future of peace and safety for all. Our prayers are with the hostages and their families. May the year ahead bring breakthroughs, healing, and homecomings. 🍎🍯 #innovation #RoshHashana

✨ Even in uncertain times, Israeli innovation thrives. Pluri CEO Yaky Yanay told @IsraelHayomHeb how 2025’s challenges proved the need for stronger food & biotech supply chains and how Israel keeps turning adversity into opportunity. 🔗 israelhayom.co.il/tech/tech-news… #Biotech #FoodTech

💡 Pluri CEO @YakyYanay on leading transformation with vision, trust & culture. From therapeutics to a scalable cell-based platform—lessons for leaders navigating change. 🎧 Listen: open.spotify.com/episode/1Se6FC… #Leadership #Innovation #CellTech #Transformation